Hanmi Pharmaceutical family feud
Scope
Date
~
-
Korean startups
Nursing caregiver matching startup Bosalpim succeeds in pre-series A funding
South Korea's senior citizen care service startup Bosalpim said on Wednesday that it has raised an undisclosed amount of pre-series A funding from K...
Dec 29, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharma, Neurolive to jointly develop new antidepressant drug
South Korea's drug company Daewoong Pharmaceutical said on Wednesday that it has signed an agreement with biopharmaceutical venture Neurorive to joi...
Dec 28, 2022 (Gmt+09:00)
-
Private equity
BASF, ADM join race to buy Korean ceramide maker Solus Biotech
BASF SE, the world’s largest chemical producer, US food processing giant ADM Co. and two other global companies have joined the race to acquir...
Dec 27, 2022 (Gmt+09:00)
-
Automobiles
Hyundai's Tucson named BBC Top Gear's Best Family Car
Hyundai Motor Co. said on Friday that its Tucson SUV has been selected as the "best family car" by the British motoring TV show Top Gear.In the rece...
Dec 23, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korea's CMG Pharmaceutical opens animal medicine unit
CMG Pharmaceutical, a subsidiary of South Korea's CHA Biotech, on Monday announced the launch of an animal medicine unit and entry into the market f...
Dec 20, 2022 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm begins clinical trials of wearable device for detecting epilepsy
SK Group's new drug development subsidiary SK Biopharmaceuticals Co. will begin clinical trials for a wearable device that can detect and predict ep...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
Daewoong submits new drug applications for Fexuclue in 10 countries
South Korea's leading drug company Daewoong Pharmaceutical is accelerating its global expansion efforts for its 34th domestically developed drug Fex...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S. Korea's SillaJen launches clinical trials in US for new anti-cancer drug
South Korean biotech company Sillajen Inc. has started recruiting patients for Phase 1 clinical trials in the US for an anti-cancer drug from a Swis...
Dec 14, 2022 (Gmt+09:00)
-
Bio & Pharma
S.Korean Proteina gets offers from global pharmaceutical companies
Global pharmaceutical companies are expressing keen interest in the South Korean diagnostics company Proteina. Unlike companies that search for sp...
Dec 12, 2022 (Gmt+09:00)
-
Bio & Pharma
Boryung holds Care-in-Space Challenge in US for space healthcare startups
South Korea's pharmaceutical company Boryeong said on Friday that it held the first "Care-in-Space Challenge" event, a new space healthcare startup ...
Dec 09, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea approves Daewoong Pharmaceutical's diabetes drug
DAEWOONG PHARMACEUTICAL has received domestic approval for its diabetes drug Envlo with the active ingredient enavogliflozin, the second straight ye...
Dec 02, 2022 (Gmt+09:00)
-
Food & Beverage
Daesang Welllife forms joint venture with Sinopharm Group
Daesang Welllife on Thursday said it has concluded a memorandum of understanding (MOU) with China Sinopharm International, an affiliate of China's l...
Dec 01, 2022 (Gmt+09:00)
-
Bio & Pharma
Spectrum to push back launch date of Hanmi-developed drug Poziotinib
Hanmi Pharmaceutical Co. announced Friday that California-based Spectrum Pharmaceuticals Inc. received a Complete Response Letter (CRL) from the US ...
Nov 25, 2022 (Gmt+09:00)
-
Bio & Pharma
JW Pharmaceutical relocates US research center from Seattle to Boston
JW Pharmaceutical announced on Wednesday that it has relocated its US research center to Boston from San Diego. JW Theriac was first establishe...
Nov 23, 2022 (Gmt+09:00)
-
Korean stock market
Samsung family’s shareholdings shrink by $8 bn in one year
Samsung Group’s four heirs to the late Chairman Lee Kun-hee have seen their group company shareholdings shrink by a combined 11 trillion won (...
Sep 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi’s anti-cancer drug Rolontis gets FDA approval; US sale via Spectrum
South Korea’s Hanmi Pharmaceutical Co. said on Tuesday that Rolontis, an anti-cancer drug it has jointly developed with its US partner, has ob...
Sep 13, 2022 (Gmt+09:00)
-
Korean games
Nexon late founder’s family inherits all his shares
The wife and two daughters of Nexon’s late founder Kim Jung-ju have inherited all his shares in the game developer’s holding company NXC...
Sep 08, 2022 (Gmt+09:00)
-
Shareholder activism
Hanjin Group management rights feud resolved with aid of LX Group
LX Pantos, an LX Group affiliate, has acquired a 3.86% stake in Hanjin KAL Corp., the holding company of Hanjin Group.The LX Group is considered a k...
Aug 29, 2022 (Gmt+09:00)
-
Korean chipmakers
Korea's Hanmi Semiconductor releases new glass micro saw
Hanmi Semiconductor Co., South Korea’s leading chip equipment maker, has launched a ‘full automation glass micro saw' dubbed GL2101 and ...
Aug 16, 2022 (Gmt+09:00)
-
IPOs
Korea’s top beauty chain CJ Olive Young puts IPO on hold
CJ Olive Young, South Korea’s top beauty store chain, has suspended its process to seek a stock market listing, becoming the latest major loca...
Aug 02, 2022 (Gmt+09:00)
-
Bio & Pharma
Korean biotech firms fold COVID-19 therapeutics development businesses
A string of South Korean pharmaceutical and biotech companies are waving the white flag when it comes to developing COVID-19 treatments. As the...
Jul 04, 2022 (Gmt+09:00)
-
Bio & Pharma
KT, Hanmi-invested therapeutics maker Digital Pharm launched
Digital Pharm, jointly invested in by KT Corp. and Hanmi Pharmaceutical Co., held an official inauguration ceremony last week, the company announced...
Jun 20, 2022 (Gmt+09:00)
-
Korean chipmakers
Hanmi Semiconductor among top 10 chip machine makers: TechInsights
Hanmi Semiconductor Co., a South Korean chip equipment manufacturer, has been chosen as one of the world’s top 10 chip fabrication machine mak...
May 24, 2022 (Gmt+09:00)
-
Automobiles
SUV, minivan sales reach 52% of car market in Q1
Sales of leisure vehicles in South Korea, primarily sport utility vehicles (SUVs) and minivans, exceeded half of domestic finished car sales in the ...
Apr 18, 2022 (Gmt+09:00)
-
Bio & Pharma
SK's biotech bets step closer to commercialization
Biotechnology startups in Europe, backed by South Korea's SK Inc., are speeding up their development of next-generation drug candidates by joining h...
Apr 15, 2022 (Gmt+09:00)
-
Bio & Pharma
FDA to review Hanmi Pharmaceutical’s Rolontis for marketing approval
The US Food and Drug Administration has begun reviewing a medicine developed by South Korea’s Hanmi Pharmaceutical Co. for marketing authoriza...
Apr 13, 2022 (Gmt+09:00)
-
Bio & Pharma
Hanmi stands out with own drugs as Korean rivals sell imports
South Korea’s Hanmi Pharmaceutical Co. generated sales of more than 1 trillion won ($812.3 million) from its own medicines last year on strong...
Apr 11, 2022 (Gmt+09:00)
-
Samsung Group
Samsung family set to sell $320 mn worth of SDS shares
Samsung Group family is set to sell a 3.9% stake in Samsung SDS Co. worth 390 billion won ($319.5 million) through a block deal. The seller is one o...
Mar 22, 2022 (Gmt+09:00)
-
Bio & Pharma
Korea Hanmi to launch blockbuster hypertension drug in China
South Korea’s Hanmi Pharmaceutical Co. is set to launch its blockbuster high blood pressure drug Amosartan in China, the world’s largest...
Mar 11, 2022 (Gmt+09:00)
language -
Shares in Nexon, two listed arms rise on M&A hopes
The unexpected death of Nexon founder Kim Jung-ju stoked market speculation about a possible change in its ownership structure and top management, s...
Mar 02, 2022 (Gmt+09:00)
Latest News
- 1 Samsung's financial arms beat No.1 banking group KB in profit
- 2 Korea’s airlines plagued by elevated fuel costs, strong dollar
- 3 LG Uplus offers Korean Air gift cards to 5G subscribers
- 4 SK Bioscience sells stake in US vaccine developer Novavax
- 5 Naver Cloud takes the lead in Korea’s public AI business